QuidelOrtho Corporation (NASDAQ: QDEL) stands out in the healthcare sector with its focus on medical devices, providing a robust range of diagnostic testing solutions. Headquartered in San Diego, California, this..
Sotera Health Company (NASDAQ: SHC) stands as a formidable entity within the healthcare sector, specifically in the diagnostics and research industry. With a market capitalization of $4.47 billion, Sotera provides..
Crinetics Pharmaceuticals, Inc. (NASDAQ: CRNX) is making waves in the biotechnology sector with its innovative approach to tackling rare endocrine diseases and endocrine-related tumors. The company, headquartered in San Diego,..
Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is a commercial-stage biopharmaceutical company that is making waves in the healthcare sector with its focus on rare diseases. With a market capitalization of $2.65..
Protagonist Therapeutics, Inc. (NASDAQ: PTGX), a notable player in the biotechnology sector, is drawing attention with its robust market presence and promising pipeline of drug candidates. With a market capitalization..
Immunovant, Inc. (NASDAQ: IMVT) is capturing investor attention with a compelling potential upside of 64.60%, according to recent analyst ratings. This clinical-stage biopharmaceutical company, based in New York, focuses on..
Scholar Rock Holding Corporation (NASDAQ: SRRK) has piqued the interest of investors with its promising biotechnology advancements and a striking 58.48% potential stock price upside. Specializing in the discovery and..
ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) stands out in the biotechnology sector, particularly for individual investors seeking opportunities within the healthcare market. With its focus on developing treatments for central nervous..
Investors seeking opportunities in the burgeoning biotechnology sector may find Xenon Pharmaceuticals Inc. (NASDAQ: XENE) an intriguing prospect. With a market capitalization of $2.97 billion, this Canadian biotech company is..
In the dynamic landscape of healthcare investments, Surgery Partners, Inc. (NASDAQ: SGRY) stands out with its intriguing potential for growth and an impressive 78.59% potential upside according to analyst ratings...
